LONGVIDA® CONFIRMED TO CROSS BLOOD BRAIN AND BLOOD RETINAL BARRIERS

A recent clinical publication in a peer-reviewed journal, JCI Insight, offers a practical, noninvasive approach to detect and monitor discrete retinal amyloid deposits in patients using solid-lipid curcumin and a modified scanning laser ophthalmoscope. The researchers conclude that the concept may lead to a practical and feasible approach for large-scale AD
diagnosis and monitoring.

The researchers present an extensive amount of quantitative and histological reports including comparative curcumin data (water
soluble, 95% curcuminoids, Longvida®) pharmacokinetic information, dose and regimen calibration, as well as human clinical data.